Epitranscriptomic events such as adenosine-to-inosine (A-to-I) RNA editing by ADAR can recode mRNAs to translate novel proteins. Editing of the mRNA that encodes actin crosslinking protein Filamin A (FLNA) mediates a Q-to-R transition in the interactive C-terminal region. While FLNA editing is conserved among vertebrates, its physiological function remains unclear. Here, we show that cardiovascular tissues in humans and mice show massive editing and that FLNA RNA is the most prominent substrate. Patient-derived RNA-Seq data demonstrate a significant drop in FLNA editing associated with cardiovascular diseases. Using mice with only impaired FLNA editing, we observed increased vascular contraction and diastolic hypertension accompanied by increased myosin light chain phosphorylation, arterial remodeling, and left ventricular wall thickening, which eventually causes cardiac remodeling and reduced systolic output. These results demonstrate a causal relationship between RNA editing and the development of cardiovascular disease indicating that a single epitranscriptomic RNA modification can maintain cardiovascular health.
Impact Factor
Scopus SNIP
Web of Science Times Cited
Scopus Cited By
Altmetric
10.557
1.622
0
57
Tags
Annotations
Special Publikation
Hide on homepage
Publication typeArticle: Journal article
Document typeScientific Article
Thesis type
Editors
KeywordsAdenosine Deaminases Acting On Rna (adar) ; Cardiovascular Disease ; Filamin A (flna) ; Hypertension ; Rna Editing